View Financial Health4Front Ventures 배당 및 자사주 매입배당 기준 점검 0/64Front Ventures 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 274Front Ventures Corp. Announces Board Resignations, Effective June 26, 20254Front Ventures Corp. announced that Kris Krane, Chairman of the Board, and David Daily, Director, have tendered their resignations from the Company's Board of Directors effective June 26, 2025. Mr. Krane was both the Chair of the Board and a member of the Audit Committee; Mr. Daily was a director and Chair of the Audit Committee.공시 • Apr 044Front Ventures Corp. Announces Board Changes4Front Ventures Corp. announced changes to its Board of Directors, provided an update on the timing of its fourth quarter and fiscal year 2024 financial results, and announced the issuance of certain equity grants in lieu of cash Board pay. Effective March 29, 2025, Chetan Gulati, Roman Tkachenko, and Leo Gontmakher have stepped down from the Company's Board of Directors. These changes are part of a broader effort to enhance governance and support the Company's long-term strategic priorities. The departing directors are affiliated with the Company's senior lenders--Mr. Gulati with Navy Capital, and Messrs. Tkachenko and Gontmakher with LI Lending --and their resignations are intended to eliminate potential conflicts of interest and enable more independent oversight and decision making in regard to those lenders. Chairman Kris Krane and Audit Chair David Daily will remain on the Board to provide continuity.공시 • Apr 014Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2025, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 084Front Ventures Corp. to Report Q3, 2024 Results on Nov 14, 20244Front Ventures Corp. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024공시 • Aug 074Front Ventures Corp. to Report Q2, 2024 Results on Aug 14, 20244Front Ventures Corp. announced that they will report Q2, 2024 results After-Market on Aug 14, 2024공시 • Jul 064Front Ventures Corp. Announces Management Changes4Front Ventures Corp. announced that current Company director Kris Krane became Chair of the Board in place of Robert Hunt, who is departing the Board. Mr. Krane has extensive experience in the cannabis industry, having previously served as the Company's President and played a key role in its growth and development. As a regulatory and business strategist, as well as a frequent speaker at cannabis conferences and events around the world, Mr. Krane has spent the last two decades working to advance the cannabis industry and movement. He has served as Associate Director of the National Organization for the Reform of Marijuana Laws ("NORML") and Executive Director of Students for Sensible Drug Policy, and is Chair Emeritus of the National Cannabis Industry Association Board of Directors. An Illinois resident, Krane's deep industry knowledge and local presence align with 4Front's strategic focus on growth in that state. Mr. Hunt's departure is not in connection with any known disagreement with the Company on any matter relating to the Company's operations, policies, or practices, including accounting principles and practices.공시 • May 16+ 1 more update4Front Ventures Corp. to Report Q1, 2024 Results on May 17, 20244Front Ventures Corp. announced that they will report Q1, 2024 results Pre-Market on May 17, 2024공시 • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 04/01/2024, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Mar 284Front Ventures Corp. to Report Q4, 2023 Results on Apr 15, 20244Front Ventures Corp. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Apr 15, 2024공시 • Jan 084Front Ventures Corp. Announces Chief Executive Officer Changes4Front Ventures Corp. announced that its board of directors have appointed Andrew Thut as Chief Executive Officer, effective January 8, 2024. Mr. Thut will succeed Leo Gontmakher, who has served as Chief Executive Officer since May 30, 2020. Mr. Gontmakher will remain on the Board as a director and serve as a consultant to the Company.공시 • Dec 124Front Ventures Corp. Debuts Cannabis Flower Brand the Hunt4Front Ventures Corp. announced the launch of cannabis flower brand, The Hunt, expanding the Company's brand portfolio in Massachusetts and adding to its growing offering of high quality, affordable flower. The Hunt's product lineup, which features exclusive offerings of rare, limited and small-batch phenotypes, is now available for purchase at 4Front's Mission Dispensaries in Georgetown, Worcester, and Brookline, MA, and at partner dispensaries across the Bay State. Each strain drop of The Hunt is only available for a limited time, while supplies last; the Company expects to introduce the new offering to Illinois cannabis consumers in first quarter 2024. Utilizing rare, heritage genetics, and creative cross breeding, The Hunt's unique and proprietary strains are available in small batches and limited releases. The latest release of The Hunt offers a lineup of indica dominant strains such as Mandarin Zkittles #4, Mandarin Zkittles #7, Mandarin Zkittles#10, Planet Sherb and Plasma Gas, as well as sativa dominant strains such as Crazey Hazey #5, Crazey Hazey #8, Killer Bees #1, and Killer Bees #6.공시 • Dec 014Front Ventures Corp. Announces Chief Financial Officer Changes4Front Ventures Corp. announced that effective November 30, 2023, Nicole Frederick resigned as Interim Chief Financial Officer to pursue another opportunity. Peter Kampian has been appointed Chief Financial Officer (CFO), effective December 1, 2023. Mr. Kampian, 64, will employ his wealth of experience in the financial sector to elevate the Company's finance and accounting functions. Kampian is a seasoned executive with over two decades of financial expertise gained through various roles, including his tenure as the Chief Financial Officer of Algonquin Power and Utilities Corp., where he led and supported debt and equity capital raising initiatives, along with numerous acquisitions. Kampian also held the role of CFO at Mettrum Health Corp., which was later acquired by Canopy Growth Corp., and serves as CFO at Electryon Power Inc. and Huxley Health Inc. In addition to his executive roles, Kampian has served on several boards, such as Aduro Clean Technologies Inc., Harborside Inc., Greenbutts Inc., Red Pine Exploration Inc., and as a director at Origin House. Most recently, he has applied his expertise as the Chief Restructuring Officer for the Canadian cannabis companies PharmHouse Inc. and Muskoka Grown Limited. He is a CPA and received a Bachelor of Business Administration from Wilfrid Laurier University.공시 • Nov 154Front Ventures Corp. announced delayed 10-Q filingOn 11/14/2023, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 024Front Ventures Corp. to Report Q3, 2023 Results on Nov 14, 20234Front Ventures Corp. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023공시 • Oct 184Front Ventures Corp. announced that it expects to receive $10 million in funding4Front Ventures Corp. announced that it has entered into a $10 million senior secured credit facility agreement on October 16, 2023. The transaction will include participation from new lender, ALT Debt II, LP, managed by Altmore Capital Investment Management, LLC. The funds will be disbursed in two tranches. The credit facility will bear simple interest at a rate per annum equal to the greater of (i) the WSJ Prime Rate plus 7% and (ii) 15.5%, payable monthly and the maturity date of the credit facility will be September 30, 2026.공시 • Sep 154Front Ventures Broadens Illinois Offerings with Expansion of Island Cannabis Co. Product Line4Front Ventures Corp. announced the expansion of its product offerings in Illinois under its premium flower brand, Island Cannabis Co. ("Island"). The lineup features a new 7g size of Island's premium flower and the soon-to-be-released Island Classic Single Strain 1g Pre-Rolls, both offered in four distinct strains -- Garlic Z, Banana Puddintain, Grease Monkey, and Duct Tape. Customers can now find the Island 7g flower offering at 4Front's Mission dispensaries in Calumet City and South Chicago, with further expansion into partner dispensaries throughout the state planned for the coming weeks. As part of the launch, 4Front is proud to introduce the Island Adventure Pack promotion in celebration of National Public Lands Day on September 23(rd) . The country's largest single-day volunteer effort is organized by the National Environmental Education Foundation (NEEF) in partnership with the National Park Service, where Americans are encouraged to show their appreciation for the environment with free admission to over 400 National Parks. With the purchase of Island flower and Island Classic Single Strain Pre-Rolls, customers will receive an Island Cannabis Co. t-shirt, perfect for an adventure in Indiana Dunes National Park, located near 4Front's Mission dispensaries in Calumet City and South Chicago. Additionally, on September 30(th), Mission Dispensaries is sponsoring the Stand Up 2 Cancer comedy show at Signature Sports Bar and Grill, located at 3215 Union Ave, Steger, IL at 8:00 pm CT. The event is in support of Zero Prostate Cancer, a leading national nonprofit with a mission to end prostate cancer and help all who are impacted, with proceeds going toward veterans undergoing treatment. In support of the initiative, 4Front is offering attendees $10 off their next purchase of $65+ at Mission dispensaries in Calumet City and South Chicago. For more information on 4Front's charitable initiatives, visit the Company's website.공시 • Aug 064Front Ventures Corp. Announces Update to Senior Management TeamEffective July 31, 2023, Keith Adams resigned as Chief Financial Officer of 4Front Ventures Corp. Keith resigned to pursue other career opportunities. Effective immediately, the company has named Director of External Reporting, Nicole Frederick, age 31, to be interim Chief Financial Officer and have begun the process of identifying Keith's successor. Nicole has served as Director of External Reporting since August 2022. She began her career at EY, a big four accounting firm, in 2014. Prior to joining the Company, she held various roles in External Reporting at an infrastructure services company. Nicole is a CPA and holds a Master's and Bachelor's degree in Accountancy from Arizona State University, W. P. Carey School of Business.공시 • Aug 034Front Ventures Corp. to Report Q2, 2023 Results on Aug 15, 20234Front Ventures Corp. announced that they will report Q2, 2023 results After-Market on Aug 15, 2023New Risk • Jun 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$92.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$96k sold). Market cap is less than US$100m (US$92.3m market cap).공시 • Jun 074Front Ventures Corp., Annual General Meeting, Jul 14, 20234Front Ventures Corp., Annual General Meeting, Jul 14, 2023, at 12:00 US Eastern Standard Time. Location: 29 Everett Street Holliston Massachusetts United States Agenda: To consider and, if thought advisable, approve a resolution setting the number of directors for the present time at 6; to elect directors of the Company for the upcoming year; to appoint Davidson & Company LLP as the auditor of the Company for the upcoming year and to authorize the directors to fix their remuneration; to consider, and if thought fit, to pass, with or without variation, an ordinary resolution ratifying, confirming and approving the Company’s stock option plans and the unallocated options thereunder; and to consider other items of business that may be properly brought before the meeting.공시 • May 23Amit Patel Steps Down as a Director of 4Front Ventures Corp4Front Ventures Corp. announced that Amit Patel has stepped down as a director and the Chair of the Audit Committee of the Company, effective May 16, 2023.공시 • May 054Front Ventures Corp. Elevates the Cannabis Infused Chocolate Category4Front Ventures Corp. announced it is elevating the cannabis-infused chocolate category, premiering "Koko Gemz Variety Pack'' in Massachusetts. The new product offering features four chocolate flavors - Milk Chocolate, Dark Chocolate, Cookies & Cream and Peanut Butter Milk Chocolate - each made by the Company's master chocolatiers using handcrafted Belgian chocolates. Using only the highest quality ingredients, 4Front combined two things it loves most - chocolate and cannabis - to create a delectable assortment of vegetarian cannabis-infused treats in one convenient box. Each variety pack contains a mix of 20 Koko Gemz with 5mg of THC, delivering a tasty tension of chocolate, luscious smoothness and 100mg of THC in each box.공시 • Feb 104Front Ventures Corp. Debuts Cannabis Blunt Brand 1988, Expanding Product Suite4Front Ventures Corp. broadened its brand portfolio with the launch of 1988, a new line of flavored, tobacco-free blunts that feature the Company's top-tier flower. 1988 is now available at 4Front's Mission Dispensaries in Georgetown, Worcester and Brookline, Massachusetts. The new brand will continue to roll out to partner dispensaries in the Bay State and to Illinois cannabis consumers later this year. The 1988 pre-rolled 1 gram blunts are packed full of 4Front's choice nugs, rolled into tobacco-free blunt cones and are available as singles in dube tubes. The filterless, slow-burning blunts are available in a variety of strains and flavors designed to enhance the strain's flavor profile and user experience.공시 • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.공시 • May 194Front Ventures Corp. announced delayed 10-Q filingOn 05/18/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 094Front Ventures Corp. Announces Resignation of Nicolle Dorsey, Chief Financial OfficerOn February 1, 2021, Nicolle Dorsey ceased serving as the Chief Financial Officer of 4Front Ventures Corp. (the “Company”). On February 3, 2021, the Company and Ms. Dorsey entered into a separation agreement (the “Separation Agreement”), under which she will continue to provide services to the Company in a temporary support role.공시 • Jan 284Front Ventures Receives Approval to Begin Construction of Mission Dispensary in Brookline, Massachusetts4Front Ventures Corp. announced that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open in second quarter 2021. 4Front's new dispensary will be located at 1024 Commonwealth Avenue in Brookline, with the storefront opening to Boston proper. The location will serve the Brookline, Allston corridor, a vibrant community within the wider Boston University and Boston metropolitan area. Mission Brookline will carry a full line of 4Front's high-quality, adult-use cannabis brands and products, including flower, extracts, edibles, and vapes. Mission's expertly trained staff will be available to ensure an informative, welcoming, and inclusive experience for all consumers. Adult-use customers will be able to browse live inventory, place online orders and pickup orders in-store.공시 • Nov 244Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million.4Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 21,430,000 Price\Range: CAD 0.7 Discount Per Security: CAD 0.042 Transaction Features: Regulation S; Rule 144A공시 • Nov 204Front Ventures Corp. to Report Q3, 2020 Results on Nov 30, 20204Front Ventures Corp. announced that they will report Q3, 2020 results on Nov 30, 2020공시 • Sep 26Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million.Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. As of September 23, 2020, Ethos Cannabis completed the acquisition of three Maryland dispensaries for approximately $5.5 million. Beacon Securities Limited acted as financial advisor to 4Front Ventures.공시 • Sep 24Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT).Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. Beacon Securities Limited acted as financial advisor to 4Front Ventures. Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT) on September 23, 2020.공시 • Aug 284Front Ventures Corp. to Report Q2, 2020 Results on Aug 31, 20204Front Ventures Corp. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 31, 2020공시 • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.공시 • Jul 184Front Ventures Corp. to Report Q1, 2020 Results on Jul 14, 20204Front Ventures Corp. announced that they will report Q1, 2020 results at 5:00 PM, Eastern Standard Time on Jul 14, 2020공시 • Jul 104Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission.4Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission on July 9, 2020.공시 • Jun 20An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.공시 • Jun 19An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.공시 • Jun 17+ 3 more updatesAn unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 FFNT.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: FFNT.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장4Front Ventures 배당 수익률 vs 시장FFNT.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (FFNT.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Pharmaceuticals)2.1%분석가 예측 (FFNT.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 FFNT.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 FFNT.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 FFNT.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: FFNT.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:14종가2026/05/18 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스4Front Ventures Corp.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jonathan DeCourceyBTIGMatt BottomleyCanaccord Genuity
공시 • Jun 274Front Ventures Corp. Announces Board Resignations, Effective June 26, 20254Front Ventures Corp. announced that Kris Krane, Chairman of the Board, and David Daily, Director, have tendered their resignations from the Company's Board of Directors effective June 26, 2025. Mr. Krane was both the Chair of the Board and a member of the Audit Committee; Mr. Daily was a director and Chair of the Audit Committee.
공시 • Apr 044Front Ventures Corp. Announces Board Changes4Front Ventures Corp. announced changes to its Board of Directors, provided an update on the timing of its fourth quarter and fiscal year 2024 financial results, and announced the issuance of certain equity grants in lieu of cash Board pay. Effective March 29, 2025, Chetan Gulati, Roman Tkachenko, and Leo Gontmakher have stepped down from the Company's Board of Directors. These changes are part of a broader effort to enhance governance and support the Company's long-term strategic priorities. The departing directors are affiliated with the Company's senior lenders--Mr. Gulati with Navy Capital, and Messrs. Tkachenko and Gontmakher with LI Lending --and their resignations are intended to eliminate potential conflicts of interest and enable more independent oversight and decision making in regard to those lenders. Chairman Kris Krane and Audit Chair David Daily will remain on the Board to provide continuity.
공시 • Apr 014Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2025, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 084Front Ventures Corp. to Report Q3, 2024 Results on Nov 14, 20244Front Ventures Corp. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024
공시 • Aug 074Front Ventures Corp. to Report Q2, 2024 Results on Aug 14, 20244Front Ventures Corp. announced that they will report Q2, 2024 results After-Market on Aug 14, 2024
공시 • Jul 064Front Ventures Corp. Announces Management Changes4Front Ventures Corp. announced that current Company director Kris Krane became Chair of the Board in place of Robert Hunt, who is departing the Board. Mr. Krane has extensive experience in the cannabis industry, having previously served as the Company's President and played a key role in its growth and development. As a regulatory and business strategist, as well as a frequent speaker at cannabis conferences and events around the world, Mr. Krane has spent the last two decades working to advance the cannabis industry and movement. He has served as Associate Director of the National Organization for the Reform of Marijuana Laws ("NORML") and Executive Director of Students for Sensible Drug Policy, and is Chair Emeritus of the National Cannabis Industry Association Board of Directors. An Illinois resident, Krane's deep industry knowledge and local presence align with 4Front's strategic focus on growth in that state. Mr. Hunt's departure is not in connection with any known disagreement with the Company on any matter relating to the Company's operations, policies, or practices, including accounting principles and practices.
공시 • May 16+ 1 more update4Front Ventures Corp. to Report Q1, 2024 Results on May 17, 20244Front Ventures Corp. announced that they will report Q1, 2024 results Pre-Market on May 17, 2024
공시 • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 04/01/2024, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 284Front Ventures Corp. to Report Q4, 2023 Results on Apr 15, 20244Front Ventures Corp. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Apr 15, 2024
공시 • Jan 084Front Ventures Corp. Announces Chief Executive Officer Changes4Front Ventures Corp. announced that its board of directors have appointed Andrew Thut as Chief Executive Officer, effective January 8, 2024. Mr. Thut will succeed Leo Gontmakher, who has served as Chief Executive Officer since May 30, 2020. Mr. Gontmakher will remain on the Board as a director and serve as a consultant to the Company.
공시 • Dec 124Front Ventures Corp. Debuts Cannabis Flower Brand the Hunt4Front Ventures Corp. announced the launch of cannabis flower brand, The Hunt, expanding the Company's brand portfolio in Massachusetts and adding to its growing offering of high quality, affordable flower. The Hunt's product lineup, which features exclusive offerings of rare, limited and small-batch phenotypes, is now available for purchase at 4Front's Mission Dispensaries in Georgetown, Worcester, and Brookline, MA, and at partner dispensaries across the Bay State. Each strain drop of The Hunt is only available for a limited time, while supplies last; the Company expects to introduce the new offering to Illinois cannabis consumers in first quarter 2024. Utilizing rare, heritage genetics, and creative cross breeding, The Hunt's unique and proprietary strains are available in small batches and limited releases. The latest release of The Hunt offers a lineup of indica dominant strains such as Mandarin Zkittles #4, Mandarin Zkittles #7, Mandarin Zkittles#10, Planet Sherb and Plasma Gas, as well as sativa dominant strains such as Crazey Hazey #5, Crazey Hazey #8, Killer Bees #1, and Killer Bees #6.
공시 • Dec 014Front Ventures Corp. Announces Chief Financial Officer Changes4Front Ventures Corp. announced that effective November 30, 2023, Nicole Frederick resigned as Interim Chief Financial Officer to pursue another opportunity. Peter Kampian has been appointed Chief Financial Officer (CFO), effective December 1, 2023. Mr. Kampian, 64, will employ his wealth of experience in the financial sector to elevate the Company's finance and accounting functions. Kampian is a seasoned executive with over two decades of financial expertise gained through various roles, including his tenure as the Chief Financial Officer of Algonquin Power and Utilities Corp., where he led and supported debt and equity capital raising initiatives, along with numerous acquisitions. Kampian also held the role of CFO at Mettrum Health Corp., which was later acquired by Canopy Growth Corp., and serves as CFO at Electryon Power Inc. and Huxley Health Inc. In addition to his executive roles, Kampian has served on several boards, such as Aduro Clean Technologies Inc., Harborside Inc., Greenbutts Inc., Red Pine Exploration Inc., and as a director at Origin House. Most recently, he has applied his expertise as the Chief Restructuring Officer for the Canadian cannabis companies PharmHouse Inc. and Muskoka Grown Limited. He is a CPA and received a Bachelor of Business Administration from Wilfrid Laurier University.
공시 • Nov 154Front Ventures Corp. announced delayed 10-Q filingOn 11/14/2023, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 024Front Ventures Corp. to Report Q3, 2023 Results on Nov 14, 20234Front Ventures Corp. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023
공시 • Oct 184Front Ventures Corp. announced that it expects to receive $10 million in funding4Front Ventures Corp. announced that it has entered into a $10 million senior secured credit facility agreement on October 16, 2023. The transaction will include participation from new lender, ALT Debt II, LP, managed by Altmore Capital Investment Management, LLC. The funds will be disbursed in two tranches. The credit facility will bear simple interest at a rate per annum equal to the greater of (i) the WSJ Prime Rate plus 7% and (ii) 15.5%, payable monthly and the maturity date of the credit facility will be September 30, 2026.
공시 • Sep 154Front Ventures Broadens Illinois Offerings with Expansion of Island Cannabis Co. Product Line4Front Ventures Corp. announced the expansion of its product offerings in Illinois under its premium flower brand, Island Cannabis Co. ("Island"). The lineup features a new 7g size of Island's premium flower and the soon-to-be-released Island Classic Single Strain 1g Pre-Rolls, both offered in four distinct strains -- Garlic Z, Banana Puddintain, Grease Monkey, and Duct Tape. Customers can now find the Island 7g flower offering at 4Front's Mission dispensaries in Calumet City and South Chicago, with further expansion into partner dispensaries throughout the state planned for the coming weeks. As part of the launch, 4Front is proud to introduce the Island Adventure Pack promotion in celebration of National Public Lands Day on September 23(rd) . The country's largest single-day volunteer effort is organized by the National Environmental Education Foundation (NEEF) in partnership with the National Park Service, where Americans are encouraged to show their appreciation for the environment with free admission to over 400 National Parks. With the purchase of Island flower and Island Classic Single Strain Pre-Rolls, customers will receive an Island Cannabis Co. t-shirt, perfect for an adventure in Indiana Dunes National Park, located near 4Front's Mission dispensaries in Calumet City and South Chicago. Additionally, on September 30(th), Mission Dispensaries is sponsoring the Stand Up 2 Cancer comedy show at Signature Sports Bar and Grill, located at 3215 Union Ave, Steger, IL at 8:00 pm CT. The event is in support of Zero Prostate Cancer, a leading national nonprofit with a mission to end prostate cancer and help all who are impacted, with proceeds going toward veterans undergoing treatment. In support of the initiative, 4Front is offering attendees $10 off their next purchase of $65+ at Mission dispensaries in Calumet City and South Chicago. For more information on 4Front's charitable initiatives, visit the Company's website.
공시 • Aug 064Front Ventures Corp. Announces Update to Senior Management TeamEffective July 31, 2023, Keith Adams resigned as Chief Financial Officer of 4Front Ventures Corp. Keith resigned to pursue other career opportunities. Effective immediately, the company has named Director of External Reporting, Nicole Frederick, age 31, to be interim Chief Financial Officer and have begun the process of identifying Keith's successor. Nicole has served as Director of External Reporting since August 2022. She began her career at EY, a big four accounting firm, in 2014. Prior to joining the Company, she held various roles in External Reporting at an infrastructure services company. Nicole is a CPA and holds a Master's and Bachelor's degree in Accountancy from Arizona State University, W. P. Carey School of Business.
공시 • Aug 034Front Ventures Corp. to Report Q2, 2023 Results on Aug 15, 20234Front Ventures Corp. announced that they will report Q2, 2023 results After-Market on Aug 15, 2023
New Risk • Jun 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$92.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$96k sold). Market cap is less than US$100m (US$92.3m market cap).
공시 • Jun 074Front Ventures Corp., Annual General Meeting, Jul 14, 20234Front Ventures Corp., Annual General Meeting, Jul 14, 2023, at 12:00 US Eastern Standard Time. Location: 29 Everett Street Holliston Massachusetts United States Agenda: To consider and, if thought advisable, approve a resolution setting the number of directors for the present time at 6; to elect directors of the Company for the upcoming year; to appoint Davidson & Company LLP as the auditor of the Company for the upcoming year and to authorize the directors to fix their remuneration; to consider, and if thought fit, to pass, with or without variation, an ordinary resolution ratifying, confirming and approving the Company’s stock option plans and the unallocated options thereunder; and to consider other items of business that may be properly brought before the meeting.
공시 • May 23Amit Patel Steps Down as a Director of 4Front Ventures Corp4Front Ventures Corp. announced that Amit Patel has stepped down as a director and the Chair of the Audit Committee of the Company, effective May 16, 2023.
공시 • May 054Front Ventures Corp. Elevates the Cannabis Infused Chocolate Category4Front Ventures Corp. announced it is elevating the cannabis-infused chocolate category, premiering "Koko Gemz Variety Pack'' in Massachusetts. The new product offering features four chocolate flavors - Milk Chocolate, Dark Chocolate, Cookies & Cream and Peanut Butter Milk Chocolate - each made by the Company's master chocolatiers using handcrafted Belgian chocolates. Using only the highest quality ingredients, 4Front combined two things it loves most - chocolate and cannabis - to create a delectable assortment of vegetarian cannabis-infused treats in one convenient box. Each variety pack contains a mix of 20 Koko Gemz with 5mg of THC, delivering a tasty tension of chocolate, luscious smoothness and 100mg of THC in each box.
공시 • Feb 104Front Ventures Corp. Debuts Cannabis Blunt Brand 1988, Expanding Product Suite4Front Ventures Corp. broadened its brand portfolio with the launch of 1988, a new line of flavored, tobacco-free blunts that feature the Company's top-tier flower. 1988 is now available at 4Front's Mission Dispensaries in Georgetown, Worcester and Brookline, Massachusetts. The new brand will continue to roll out to partner dispensaries in the Bay State and to Illinois cannabis consumers later this year. The 1988 pre-rolled 1 gram blunts are packed full of 4Front's choice nugs, rolled into tobacco-free blunt cones and are available as singles in dube tubes. The filterless, slow-burning blunts are available in a variety of strains and flavors designed to enhance the strain's flavor profile and user experience.
공시 • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.
공시 • May 194Front Ventures Corp. announced delayed 10-Q filingOn 05/18/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 094Front Ventures Corp. Announces Resignation of Nicolle Dorsey, Chief Financial OfficerOn February 1, 2021, Nicolle Dorsey ceased serving as the Chief Financial Officer of 4Front Ventures Corp. (the “Company”). On February 3, 2021, the Company and Ms. Dorsey entered into a separation agreement (the “Separation Agreement”), under which she will continue to provide services to the Company in a temporary support role.
공시 • Jan 284Front Ventures Receives Approval to Begin Construction of Mission Dispensary in Brookline, Massachusetts4Front Ventures Corp. announced that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open in second quarter 2021. 4Front's new dispensary will be located at 1024 Commonwealth Avenue in Brookline, with the storefront opening to Boston proper. The location will serve the Brookline, Allston corridor, a vibrant community within the wider Boston University and Boston metropolitan area. Mission Brookline will carry a full line of 4Front's high-quality, adult-use cannabis brands and products, including flower, extracts, edibles, and vapes. Mission's expertly trained staff will be available to ensure an informative, welcoming, and inclusive experience for all consumers. Adult-use customers will be able to browse live inventory, place online orders and pickup orders in-store.
공시 • Nov 244Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million.4Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 21,430,000 Price\Range: CAD 0.7 Discount Per Security: CAD 0.042 Transaction Features: Regulation S; Rule 144A
공시 • Nov 204Front Ventures Corp. to Report Q3, 2020 Results on Nov 30, 20204Front Ventures Corp. announced that they will report Q3, 2020 results on Nov 30, 2020
공시 • Sep 26Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million.Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. As of September 23, 2020, Ethos Cannabis completed the acquisition of three Maryland dispensaries for approximately $5.5 million. Beacon Securities Limited acted as financial advisor to 4Front Ventures.
공시 • Sep 24Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT).Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. Beacon Securities Limited acted as financial advisor to 4Front Ventures. Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT) on September 23, 2020.
공시 • Aug 284Front Ventures Corp. to Report Q2, 2020 Results on Aug 31, 20204Front Ventures Corp. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 31, 2020
공시 • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.
공시 • Jul 184Front Ventures Corp. to Report Q1, 2020 Results on Jul 14, 20204Front Ventures Corp. announced that they will report Q1, 2020 results at 5:00 PM, Eastern Standard Time on Jul 14, 2020
공시 • Jul 104Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission.4Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission on July 9, 2020.
공시 • Jun 20An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.
공시 • Jun 19An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.
공시 • Jun 17+ 3 more updatesAn unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.